200
评论
查看更多
密码过期或已经不安全,请修改密码
修改密码壹生身份认证协议书
同意
拒绝
同意
拒绝
同意
不同意并跳过
BCL2抑制剂 Venetoclax联合化疗在3例复发难治急性髓系白血病中的应用及文献复习*
宗香萍1 杨贞1 周进1 李静1 李彩霞1 吴德沛1
[关键词] 复发难治急性髓系白血病;BCL2抑制剂;Venetoclax
DOI:10.13201/j.issn.1004-2806.2021.07.013
[中图分类号] R733.71 [文献标志码] D
Application of BCL2inhibitor Venetoclax combined with chemotherapy in three recurrent and refractory acute myeloid leukemia patients andliterature review
Key words refractory/recurrent acute myeloid leukemia;BCL2inhibitor;Venetoclax
2 讨论
参考文献
[13]Han L,Zhang Q,Shi C,et al.Concomitantly Targe-ting BCL-2 with Venetoclax(ABT-199/GDC0199)and MAPK Signaling with Cobimetinib(GDC-0973)in Acute Myeloid Leukemia Models[J].Blood,2015,126(23):2544-2544.
查看更多